ReP USP - Resultado da busca

Artigo de periodico
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children (2024)
Bastard, Paul ; Adrian, Gervais ; Taniguchi, Maki ; Saare, Liisa ; Särekannu, Karita ; Voyer, Tom Le ; Philippot, Quentin ; Rosain, Jérémie ; Bizien, Lucy ; Asano, Takaki Asano ; Garcia-Prat, Marina ; Parra-Martínez, Alba ; Migaud, Mélanie ; Tsumura, Miyuki ; Conti, Francesca ; Belot, Alexandre ; Rivière, Jacques G. ; Morio, Tomohiro ; Tanaka, Junko ; Javouhey, Etienne ; Haerynck, Filomeen ; Duvlis, Sotirija ; Ozcelik, Tayfun ; Keles, Sevgi ; Redondo, Yacine Tandjaoui-Lambiotte ; Escoda, Simon ; Husain, Maya ; Pan-Hammarström, Qiang ; Hammarström, Lennart ; Ahlijah, Gloria ; Haidar, Anthony Abi ; Soudee, Camile ; Arsegue, Vincent; Abolhassani, Hassan ; Sahanic, Sabina ; Tancevsk, Ivan ; Nukui, Yoko ; Hayakawa, Seiichi ; Chrousos, George P. ; Michos, Athanasios ; Tatsi, Elizabeth-Barbara ; Filippatos, Filippos ; Seuma, Agusti Rodriguez-Palmero ; Garcia, Jésus Troya ; Tipu, Imran ; Meyts, Isabelle ; Roussel, Lucie ; Ostrowski, Sisse Rye ; Schidlowski, Laire ; Prando, Carolina ; Cheikh, Nathalie ; Bousfiha, Ahmed Aziz ; Bakkouri, Jalila El ; Peterson, Pärt ; Pujol, Aurora ; Lévy, Romain ; Quartier, Pierre ; Vinh, Donalod C. ; Boisson, Bertrand ; Béziat, Vivien ; Zhang, Shen-Ying ; Borghesi, Alessandro ; Pession, Andrea ; Andreakos, Evangelos ; Marr, Nico ; Mentis, Alexios-Fotios A. ; Mogensen, Trine Hyrup ; Rodríiguez-Gallego, Carlos ; Soler-Palacín, Pere ; Colobran, Roger ; Tillmann, Vallo ; Neven, Bénédicte ; Trouillet-Assant, Sophie ; Brodin, Peter ; Abel, Laurent ; Jouanguy, Emmanuelle ; Zhang, Qian ; Martinón-Torres, Federico ; Ellacuriaga, Antonio Sallas ; Gómez-Carballa, Alberto ; Gonzalez-Granado, Luis Ignacio ; Kisan, Kai ; Okada, Satoshi ; Puel, Anne ; Cobat, Aurélie ; Casanova, Jean-Laurent ; Condino Neto, Antonio
Source: The Journal of Experimental Medicine. Unidade: ICB
Subjects: IMUNOLOGIA, AUTOANTICORPOS, COVID-19, PNEUMONIA, PNEUMOPATIAS, INTERFERON TIPO I, INTERFERONS, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. The Journal of Experimental Medicine, v. 221, n. 2, p. 45 , 2024Tradução . . Disponível em: https://doi.org/10.1084/jem.20231353. Acesso em: 14 nov. 2024.
APA
Bastard, P., Adrian, G., Taniguchi, M., Saare, L., Särekannu, K., Voyer, T. L., et al. (2024). Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. The Journal of Experimental Medicine, 221( 2), 45 . doi:10.1084/jem.20231353
NLM
Bastard P, Adrian G, Taniguchi M, Saare L, Särekannu K, Voyer TL, Philippot Q, Rosain J, Bizien L, Asano TA, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Redondo YT-L, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Haidar AA, Soudee C, Arsegue V, Abolhassani H, Sahanic S, Tancevsk I, Nukui Y, Hayakawa S, Chrousos GP, Michos A, Tatsi E-B, Filippatos F, Seuma AR-P, Garcia JT, Tipu I, Meyts I, Roussel L, Ostrowski SR, Schidlowski L, Prando C, Cheikh N, Bousfiha AA, Bakkouri JE, Peterson P, Pujol A, Lévy R, Quartier P, Vinh DC, Boisson B, Béziat V, Zhang S-Y, Borghesi A, Pession A, Andreakos E, Marr N, Mentis A-FA, Mogensen TH, Rodríiguez-Gallego C, Soler-Palacín P, Colobran R, Tillmann V, Neven B, Trouillet-Assant S, Brodin P, Abel L, Jouanguy E, Zhang Q, Martinón-Torres F, Ellacuriaga AS, Gómez-Carballa A, Gonzalez-Granado LI, Kisan K, Okada S, Puel A, Cobat A, Casanova J-L, Condino Neto A. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children [Internet]. The Journal of Experimental Medicine. 2024 ; 221( 2): 45 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1084/jem.20231353
Vancouver
Bastard P, Adrian G, Taniguchi M, Saare L, Särekannu K, Voyer TL, Philippot Q, Rosain J, Bizien L, Asano TA, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Redondo YT-L, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Haidar AA, Soudee C, Arsegue V, Abolhassani H, Sahanic S, Tancevsk I, Nukui Y, Hayakawa S, Chrousos GP, Michos A, Tatsi E-B, Filippatos F, Seuma AR-P, Garcia JT, Tipu I, Meyts I, Roussel L, Ostrowski SR, Schidlowski L, Prando C, Cheikh N, Bousfiha AA, Bakkouri JE, Peterson P, Pujol A, Lévy R, Quartier P, Vinh DC, Boisson B, Béziat V, Zhang S-Y, Borghesi A, Pession A, Andreakos E, Marr N, Mentis A-FA, Mogensen TH, Rodríiguez-Gallego C, Soler-Palacín P, Colobran R, Tillmann V, Neven B, Trouillet-Assant S, Brodin P, Abel L, Jouanguy E, Zhang Q, Martinón-Torres F, Ellacuriaga AS, Gómez-Carballa A, Gonzalez-Granado LI, Kisan K, Okada S, Puel A, Cobat A, Casanova J-L, Condino Neto A. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children [Internet]. The Journal of Experimental Medicine. 2024 ; 221( 2): 45 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1084/jem.20231353
Artigo de periodico-carta/editorial
Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β (2021)
Vinh, Donald C. ; Abel, Laurent ; Bastard, Paul ; Cheng, Matthew P. ; Condino Neto, Antonio ; Gregersen, Peter K. ; Haerynck, Filomeen ; Cicalese, Maria-Pia ; Hagin, David; Palacín, Pere Soler ; Planas, Anna M. ; Pujol, Aurora ; Notarangelo, Luigi D. ; Zhang, Qian ; Su, Helen C. ; Casanova, Jean-Laurent ; Meyts, Isabelle
Source: Journal of Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNIDADE, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGENÉTICA, COVID-19, INTERFERON TIPO I, INFECÇÕES POR CORONAVIRUS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINH, Donald C. et al. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s10875-021-01068-6. Acesso em: 14 nov. 2024. , 2021
APA
Vinh, D. C., Abel, L., Bastard, P., Cheng, M. P., Condino Neto, A., Gregersen, P. K., et al. (2021). Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1007/s10875-021-01068-6
NLM
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Vancouver
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Artigo de periodico-carta/editorial
Primary immunodeficiencies: a decade of progress and a promising future (2021)
Meyts, Isabelle ; Bousfiha, Aziz; Duff, Carla ; Singh, Surjit; Lau, Yu Lung ; Condino Neto, Antonio ; Bezrodnik, Liliana ; Ali, Adli ; Adeli, Mehdi ; Drabwell, José
Source: Frontiers in Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, COVID-19, IMUNOGENÉTICA, INFECÇÕES POR CORONAVIRUS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEYTS, Isabelle et al. Primary immunodeficiencies: a decade of progress and a promising future. Frontiers in Immunology. Lausanne: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fimmu.2020.625753. Acesso em: 14 nov. 2024. , 2021
APA
Meyts, I., Bousfiha, A., Duff, C., Singh, S., Lau, Y. L., Condino Neto, A., et al. (2021). Primary immunodeficiencies: a decade of progress and a promising future. Frontiers in Immunology. Lausanne: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.3389/fimmu.2020.625753
NLM
Meyts I, Bousfiha A, Duff C, Singh S, Lau YL, Condino Neto A, Bezrodnik L, Ali A, Adeli M, Drabwell J. Primary immunodeficiencies: a decade of progress and a promising future [Internet]. Frontiers in Immunology. 2021 ; 11 5 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fimmu.2020.625753
Vancouver
Meyts I, Bousfiha A, Duff C, Singh S, Lau YL, Condino Neto A, Bezrodnik L, Ali A, Adeli M, Drabwell J. Primary immunodeficiencies: a decade of progress and a promising future [Internet]. Frontiers in Immunology. 2021 ; 11 5 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fimmu.2020.625753
Artigo de periodico
In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling (2021)
Romualdo, Guilherme Ribeiro; Leroy, Kaat ; Costa, Cícero Júlio Silva ; Prata, Gabriel Bacil ; Vanderborght, Bart; Silva, Tereza Cristina da; Barbisan, Luis Fernando ; Andraus, Wellington ; Devisscher, Lindsey ; Câmara, Niels Olsen Saraiva ; Vinken, Mathieu ; Cogliati, Bruno
Source: Cancers. Unidades: FM, ICB, FMVZ
Subjects: CARCINOMA HEPATOCELULAR, MODELOS ANIMAIS DE DOENÇAS, MODELOS FISIOLÓGICOS, HEPATOPATIAS, CARCINOGÊNESE ANIMAL, MUATAÇÃO GÊNICA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMUALDO, Guilherme Ribeiro et al. In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling. Cancers, v. 13, n. 21, p. 1-57, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13215583. Acesso em: 14 nov. 2024.
APA
Romualdo, G. R., Leroy, K., Costa, C. J. S., Prata, G. B., Vanderborght, B., Silva, T. C. da, et al. (2021). In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling. Cancers, 13( 21), 1-57. doi:10.3390/cancers13215583
NLM
Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, Silva TC da, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling [Internet]. Cancers. 2021 ; 13( 21): 1-57.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/cancers13215583
Vancouver
Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, Silva TC da, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling [Internet]. Cancers. 2021 ; 13( 21): 1-57.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/cancers13215583
Artigo de periodico-carta/editorial
Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Su, Helen C. ; Casanova, Jean-Laurent ; Spaan, András N. ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, CORONAVIRUS, GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41590-021-01096-9. Acesso em: 14 nov. 2024. , 2021
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1038/s41590-021-01096-9
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Artigo de periodico
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, GENÉTICA MÉDICA, INTERFERON TIPO I, QUIMIOCINAS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, p. 1-6, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41590-021-01030-z. Acesso em: 14 nov. 2024.
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, 1-6. doi:10.1038/s41590-021-01030-z
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 14 nov. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) (2021)
Roos, Dirk; Leeuwen, Karin van; Hsu, Amy P.; Priel, Debra Long ; Begtrup, Amber ; Brandon, Rhonda; Stasia, Marie José ; Bakri, Faris Ghalib ; Köker, Nezihe ; Köker, Mustafa Yavuz ; Madkaika, Manisha; Boer, Martin de ; Morato, Maria Bravo Garcia ; Shephard, Juan Luis Valdivieso; Roesler, Joachim ; Kanegane, Hirokazu ; Kawai, Toshinao ; Matteo, Gigliola Di ; Shahrooei, Mohammad ; Bustamante, Jacinta ; Rawat, Amit ; Vignesh, Pandiarajan ; Mortaz, Esmaeil ; Fayezi, Abbas; Cagdas, Deniz ; Tezcan, Ilhan ; Kitcharoensakkul, Maleewan ; Dinauer, Mary C. ; Meyts, Isabelle; Wolach, Baruch; Condino Neto, Antonio ; Zerbe, Christa S. ; Holland, Steven M.; Malech, Harry L. ; Gallin, John I.; Kuhns, Douglas B.
Source: Blood Cells, Molecules and Diseases. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, MUTAÇÃO GENÉTICA, DOENÇAS SANGUÍNEAS E LINFÁTICAS, SUPERÓXIDO DISMUTASE, ATIVAÇÃO ENZIMÁTICA, IMUNOGENÉTICA, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROOS, Dirk et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules and Diseases, v. 90, p. 1-36, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2021.102587. Acesso em: 14 nov. 2024.
APA
Roos, D., Leeuwen, K. van, Hsu, A. P., Priel, D. L., Begtrup, A., Brandon, R., et al. (2021). Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules and Diseases, 90, 1-36. doi:10.1016/j.bcmd.2021.102587
NLM
Roos D, Leeuwen K van, Hsu AP, Priel DL, Begtrup A, Brandon R, Stasia MJ, Bakri FG, Köker N, Köker MY, Madkaika M, Boer M de, Morato MBG, Shephard JLV, Roesler J, Kanegane H, Kawai T, Matteo GD, Shahrooei M, Bustamante J, Rawat A, Vignesh P, Mortaz E, Fayezi A, Cagdas D, Tezcan I, Kitcharoensakkul M, Dinauer MC, Meyts I, Wolach B, Condino Neto A, Zerbe CS, Holland SM, Malech HL, Gallin JI, Kuhns DB. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) [Internet]. Blood Cells, Molecules and Diseases. 2021 ; 90 1-36.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bcmd.2021.102587
Vancouver
Roos D, Leeuwen K van, Hsu AP, Priel DL, Begtrup A, Brandon R, Stasia MJ, Bakri FG, Köker N, Köker MY, Madkaika M, Boer M de, Morato MBG, Shephard JLV, Roesler J, Kanegane H, Kawai T, Matteo GD, Shahrooei M, Bustamante J, Rawat A, Vignesh P, Mortaz E, Fayezi A, Cagdas D, Tezcan I, Kitcharoensakkul M, Dinauer MC, Meyts I, Wolach B, Condino Neto A, Zerbe CS, Holland SM, Malech HL, Gallin JI, Kuhns DB. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) [Internet]. Blood Cells, Molecules and Diseases. 2021 ; 90 1-36.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bcmd.2021.102587
Artigo de periodico
The global response to the COVID-19 pandemic: how have immunology societies contributed ? (2020)
Osier, Faith; Ting, Jenny P. Y.; Fraser, John; Lambrecht, Bart N.; Romano, Marta; Gazzinelli, Ricardo Tostes ; Bortoluci, Karina Ramalho ; Zamboni, Dario Simões ; Akbar, Arne N.; Evans, Jennie; Brown, Doug E.; Patel, Kamala D.; Wu, Yuzhang; Perez, Ana Beatriz Alvarez; Pérez, Oliver; Kamradt, Thomas; Falk, Christine; Barda-Saad, Mira; Ariel, Amiram; Santoni, Angela; Annunziato, Francesco; Cassatella, Marco A.; Kiyono, Hiroshi; Chereshnev, Valeriy; Dieye, Alioune; Mbow, Moustapha; Mbengue, Babacar; Niang, Maguette D. S.; Suchard, Melinda
Source: Nature Reviews Immunology. Unidade: FMRP
Subjects: ANTIVIRAIS, USOS TERAPÊUTICOS, IMUNOLOGIA, COVID-19, INFECÇÕES POR CORONAVIRUS, PREVENÇÃO DE DOENÇAS, EPIDEMIOLOGIA, VACINAS, EDUCAÇÃO DO PACIENTE, EQUIPAMENTO DE PROTEÇÃO INDIVIDUAL, PNEUMONIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSIER, Faith et al. The global response to the COVID-19 pandemic: how have immunology societies contributed ?. Nature Reviews Immunology, v. 20, p. 594-602, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41577-020-00428-4. Acesso em: 14 nov. 2024.
APA
Osier, F., Ting, J. P. Y., Fraser, J., Lambrecht, B. N., Romano, M., Gazzinelli, R. T., et al. (2020). The global response to the COVID-19 pandemic: how have immunology societies contributed ? Nature Reviews Immunology, 20, 594-602. doi:10.1038/s41577-020-00428-4
NLM
Osier F, Ting JPY, Fraser J, Lambrecht BN, Romano M, Gazzinelli RT, Bortoluci KR, Zamboni DS, Akbar AN, Evans J, Brown DE, Patel KD, Wu Y, Perez ABA, Pérez O, Kamradt T, Falk C, Barda-Saad M, Ariel A, Santoni A, Annunziato F, Cassatella MA, Kiyono H, Chereshnev V, Dieye A, Mbow M, Mbengue B, Niang MDS, Suchard M. The global response to the COVID-19 pandemic: how have immunology societies contributed ? [Internet]. Nature Reviews Immunology. 2020 ; 20 594-602.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41577-020-00428-4
Vancouver
Osier F, Ting JPY, Fraser J, Lambrecht BN, Romano M, Gazzinelli RT, Bortoluci KR, Zamboni DS, Akbar AN, Evans J, Brown DE, Patel KD, Wu Y, Perez ABA, Pérez O, Kamradt T, Falk C, Barda-Saad M, Ariel A, Santoni A, Annunziato F, Cassatella MA, Kiyono H, Chereshnev V, Dieye A, Mbow M, Mbengue B, Niang MDS, Suchard M. The global response to the COVID-19 pandemic: how have immunology societies contributed ? [Internet]. Nature Reviews Immunology. 2020 ; 20 594-602.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/s41577-020-00428-4
Artigo de periodico
Systems analysis of protective immune responses to RTS,S malaria vaccination in humans (2017)
Kazmin, Dmitri; Nakaya, Helder Takashi Imoto ; Lee, Eva K; Johnson, Matthew J; Van der Most, Robbert; Van den Berg, Robert A; Ballou, W Ripley; Jongert, Erik; Wille-Reece, Ulrike; Ockenhouse, Christian; Aderem, Alan; Zak, Daniel E; Sadoff, Jerald; Hendriks, Jenny; Wrammert, Jens; Ahmed, Rafi; Pulendran, Bali
Source: Proceedings of the National Academy of Sciences of the United States of America. Unidade: FCF
Subjects: MALÁRIA, IMUNOLOGIA, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAZMIN, Dmitri et al. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans. Proceedings of the National Academy of Sciences of the United States of America, v. 114, n. 9, p. 2425-2430, 2017Tradução . . Disponível em: https://doi.org/10.1073/pnas.1621489114. Acesso em: 14 nov. 2024.
APA
Kazmin, D., Nakaya, H. T. I., Lee, E. K., Johnson, M. J., Van der Most, R., Van den Berg, R. A., et al. (2017). Systems analysis of protective immune responses to RTS,S malaria vaccination in humans. Proceedings of the National Academy of Sciences of the United States of America, 114( 9), 2425-2430. doi:10.1073/pnas.1621489114
NLM
Kazmin D, Nakaya HTI, Lee EK, Johnson MJ, Van der Most R, Van den Berg RA, Ballou WR, Jongert E, Wille-Reece U, Ockenhouse C, Aderem A, Zak DE, Sadoff J, Hendriks J, Wrammert J, Ahmed R, Pulendran B. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans [Internet]. Proceedings of the National Academy of Sciences of the United States of America. 2017 ; 114( 9): 2425-2430.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1073/pnas.1621489114
Vancouver
Kazmin D, Nakaya HTI, Lee EK, Johnson MJ, Van der Most R, Van den Berg RA, Ballou WR, Jongert E, Wille-Reece U, Ockenhouse C, Aderem A, Zak DE, Sadoff J, Hendriks J, Wrammert J, Ahmed R, Pulendran B. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans [Internet]. Proceedings of the National Academy of Sciences of the United States of America. 2017 ; 114( 9): 2425-2430.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1073/pnas.1621489114
Artigo de periodico
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation (2017)
Morena, Maria Teresa de la ; Leonard, David; Torgerson, Troy R.; Marques, Otavio Cabral; Slatter, Mary Anne; Aghamohammadi, Asghar ; Chandra, Sharat; Favela, Luis Murguia ; Bonilla, Francisco A. ; Kanariou, Maria; Damrongwatanasuk, Rongras; Kuo, Caroline Y.; Dvorak, Christopher C. ; Meyts, Isabelle; Chen, Karin ; Kobrynski, Lisa ; Kapoor, Neena; Richter, Darko ; DiGiovanni, Daniela; Dhalla, Fatima ; Farmaki, Evangelia ; Speckmann, Carsten ; Español, Teresa; Shcherbina, Anna YU ; Hanson, Imelda Celine Guerra; Litzman, Jiri ; Routes, John M. ; Wong, Melanie; Fuleihan, Ramsay ; Seneviratne, Suranjith L. ; Small, Trudy N.; Janda, Ales ; Bezrodnik, Liliana; Seger, Reinhard; Raccio, Andrea Gomez; Edgar, John David M. ; Chou, Janet ; Abbott, Jordan Keith ; Montfrans, Joris van ; Granado, Luis Ignacio González ; Bunin, Nancy; Kutukculer, Necil ; Gray, Paul ; Seminario, Gisela; Pasic, Srdjan ; Aquino, Victor; Wysocki, Christian ; Abolhassani, Hassan ; Dorsey, Morna ; Rundles, Charlotte Cunningham ; Knutsen, Alan Paul ; Sleasman, John William ; Carvalho, Beatriz Tavares Costa ; Condino-Neto, Antonio ; Grunebaum, Eyal ; Chapel, Helen ; Ochs, Hans Dieter; Filipovich, Alexandra Hult; Cowan, Mort; Gennery, Andrew ; Cant, Andrew James ; Notarangelo, Luigi D. ; Roifman, Chaim M.
Source: Journal of Allergy and Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, CÉLULAS-TRONCO, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, HEMATOPOESE, CÉLULAS SANGUÍNEAS, IMUNOLOGIA CELULAR, DOENÇAS AUTOIMUNES, DOENÇAS IMUNOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENA, Maria Teresa de la et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology, v. 139, n. 4, p. 1282-1292, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2016.07.039. Acesso em: 14 nov. 2024.
APA
Morena, M. T. de la, Leonard, D., Torgerson, T. R., Marques, O. C., Slatter, M. A., Aghamohammadi, A., et al. (2017). Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology, 139( 4), 1282-1292. doi:10.1016/j.jaci.2016.07.039
NLM
Morena MT de la, Leonard D, Torgerson TR, Marques OC, Slatter MA, Aghamohammadi A, Chandra S, Favela LM, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Español T, Shcherbina AYU, Hanson ICG, Litzman J, Routes JM, Wong M, Fuleihan R, Seneviratne SL, Small TN, Janda A, Bezrodnik L, Seger R, Raccio AG, Edgar JDM, Chou J, Abbott JK, Montfrans J van, Granado LIG, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, Dorsey M, Rundles CC, Knutsen AP, Sleasman JW, Carvalho BTC, Condino-Neto A, Grunebaum E, Chapel H, Ochs HD, Filipovich AH, Cowan M, Gennery A, Cant AJ, Notarangelo LD, Roifman CM. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 4): 1282-1292.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.039
Vancouver
Morena MT de la, Leonard D, Torgerson TR, Marques OC, Slatter MA, Aghamohammadi A, Chandra S, Favela LM, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Español T, Shcherbina AYU, Hanson ICG, Litzman J, Routes JM, Wong M, Fuleihan R, Seneviratne SL, Small TN, Janda A, Bezrodnik L, Seger R, Raccio AG, Edgar JDM, Chou J, Abbott JK, Montfrans J van, Granado LIG, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, Dorsey M, Rundles CC, Knutsen AP, Sleasman JW, Carvalho BTC, Condino-Neto A, Grunebaum E, Chapel H, Ochs HD, Filipovich AH, Cowan M, Gennery A, Cant AJ, Notarangelo LD, Roifman CM. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 4): 1282-1292.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.039
Artigo de periodico
Nasal polyp-derived mesenchymal stromal cells exhibit lack of imune-associated molecules and high levels of stem/progenitor cells markers (2017)
Oliveira, Pedro Wey Barbosa de; Pezato, Rogério; Agudelo, Juan Sebastian Henao; Perez-Novo, Claudina Angela; Berghe, Wim Vanden; Câmara, Niels Olsen Saraiva ; Almeida, Danilo Candido de; Gregorio, Luís Carlos
Source: Frontiers in Immunology. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Pedro Wey Barbosa de et al. Nasal polyp-derived mesenchymal stromal cells exhibit lack of imune-associated molecules and high levels of stem/progenitor cells markers. Frontiers in Immunology, v. 8, n. 39, p. 1-11, 2017Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2017.00039. Acesso em: 14 nov. 2024.
APA
Oliveira, P. W. B. de, Pezato, R., Agudelo, J. S. H., Perez-Novo, C. A., Berghe, W. V., Câmara, N. O. S., et al. (2017). Nasal polyp-derived mesenchymal stromal cells exhibit lack of imune-associated molecules and high levels of stem/progenitor cells markers. Frontiers in Immunology, 8( 39), 1-11. doi:10.3389/fimmu.2017.00039
NLM
Oliveira PWB de, Pezato R, Agudelo JSH, Perez-Novo CA, Berghe WV, Câmara NOS, Almeida DC de, Gregorio LC. Nasal polyp-derived mesenchymal stromal cells exhibit lack of imune-associated molecules and high levels of stem/progenitor cells markers [Internet]. Frontiers in Immunology. 2017 ; 8( 39): 1-11.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fimmu.2017.00039
Vancouver
Oliveira PWB de, Pezato R, Agudelo JSH, Perez-Novo CA, Berghe WV, Câmara NOS, Almeida DC de, Gregorio LC. Nasal polyp-derived mesenchymal stromal cells exhibit lack of imune-associated molecules and high levels of stem/progenitor cells markers [Internet]. Frontiers in Immunology. 2017 ; 8( 39): 1-11.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fimmu.2017.00039
Artigo de periodico
Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery (2016)
Scott, Eric M.; Halees, A.; Itan, Y.; Spencer, E. G.; He,Y.; Azab, M. A.; Gabriel, S. B.; Belkadi, A.; Boisson, B.; Abel, L.; Clark, A. G.; Consortium, Greater Middle East Variome; Alkuraya, F. S.; Casanova, J. L.; Gleeson, J. G.; Rahim, S. A.; Abdel-Hadi, S.; Abdel-Salam, G.; Abdel-Salam, E.; Abdou, M.; Abhytankar, A.; Adimi, P.; Ahmad, J.; Akcakus, M.; Aksu, G.; Hajjar, S. A.; Juamaah, S. A.; Muhsen, S. A.; Sannaa, N. A.; Tameni, S. A.; Al-Aama, J.; Al-Allawi, N.; Al-Baradie, R.; Al-Gazali, L.; Al-Hashem, A.; Al-Herz, W.; Al-Jeaid, D.; Al-Tawari, A.; Alangari, A.; Alcais, A.; AlFawaz, T.; Alsum, Z.; Ammar-Khodja, A.; Amouian, S.; Ammar-Khodja, A.; Arikan, C.; Aryani, O.; Aslanger, A.; Aydogmus, C.; Aytekin, C.; Azam, M.; Bansagi, B.; Barbouche, M. R.; Bastaki, L.; Ben-Omran, T.; Bindu, P. S.; Blancas, L.; Boisson-Dupuis, S.; Bonnet, D.; Stambouli, O. B.; Bousfiha, A.; Boussafara, L.; Boutros, J.; Bustamante, J.; Caksen, H.; Camcioglu, Y.; Catherinot, E.; Celik, F. C.; Ciancanelli, M.; Cipe, F. E.; Clark, G.; Cobat, A.; Comu, S.; Condie, A.; Condino-Neto, A.; Desai, M.; Dobyns, W.; Dogu, F.; Domaia, M.; Egritas, O.; Azbaoui, S. E.; Baghdadi, J. E.; Ruby, M. E.; El-Harouni, A.; Elfeky,R. A.; Elghazali, G.; Faqeih, E.; Fenerci, E.; Fieschi, C.; Funda, C.; Gamal, I.; Gelik, U.; Genel, F.; Gezdirici, A.; Girisha, K. M.; Goldstein, A.; Grattan-Smith, P.; Gupta, N.; Hahn, J.; Hatipoglu, N.; Hennekam, R.; Houshmand, M.; Ichai, P.; Ikinciogullari, A.; Ismail, S.; Jalas, C.; Jouanguy, E.; Kabra, M.; Kalkan, G.; Kara, M.; Karaca, N.; Karaer, K.; Kariminejad, A.; Kayserili, H.; Keser-Emiroglu, M.; Kilic, S. S.; Kissani, N.; Kokron, C.; Koul, R.; Kutukculer, N.; Lanternier, F.; Mahdaviani, A.; Mahlaoui, N.; Mansour, L.; Mansouri, D.; Margari, L.; Valente, E. M.; Marzouki, N.; Masri, A.; Megahed, A.; Megahed, H.; Mekki, N.; Mesdaghi, M.; Mikati, M.; Mojahedi, F.; Mulley, J.; Nampoothiri, S.; Navarrete, C.; Omar, T.; Oraby, A.; Pandaluz, A.; Parvaneh, N.; Patiroglu, T.; Koc, Z. P.; Pellier, I.; Picard, C.; Puel, A.; Raas-Rothschild, A.; Rajab, A.; Raoult, D.; Reisli, I.; Rezaei, N.; Sabri, A.; Sahin, Y.; Saleem, L.; Salem, F.; AlSediq, N. S.; Sanal, O.; Sanger, T.; Shakankiry, H.; Shang, L.; Shehata, N.; Shembesh, N.; Shkalim, V.; Softah, A.; Sogaty, S.; Soliman, N.; Sonmez Aunaci, F.; Sztriha, L.; Taibi-Berrah, L.; Temtamy, S.; Tonekaboni, H.; Trauner, D.; Tuysuz, B.; Varan, A.; Vogt, G.; Walsh, C.; Woods, G.; Yesil, G.; Yildiran, A.; Yildiz, B.; Yuksel, A.; Zaki, M.; Zhang, S. Y.
Source: Nature Genetics. Unidade: ICB
Subjects: VARIAÇÃO GENÉTICA, GENÉTICA, GENÉTICA DE POPULAÇÕES, IMUNOLOGIA, ALELOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCOTT, Eric M. et al. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, v. 48, n. 9, p. 1071-1076, 2016Tradução . . Disponível em: https://doi.org/10.1038/ng.3592. Acesso em: 14 nov. 2024.
APA
Scott, E. M., Halees, A., Itan, Y., Spencer, E. G., He, Y., Azab, M. A., et al. (2016). Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, 48( 9), 1071-1076. doi:10.1038/ng.3592
NLM
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/ng.3592
Vancouver
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1038/ng.3592

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration